Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.

Mechanisms of liver fibrosis in metabolic syndrome

Open access
Mehal, Wajahat · 2023 · eGastroenterology

Abstract

The understanding of the mechanisms of liver fibrosis has been dominated by models in which chronic hepatocellular injury is the initiating step as is seen with viral infections. The increased prevalence of the metabolic syndrome, and the increases in liver fibrosis due to metabolic syndrome driven non-alcoholic steatohepatitis (NASH), has made it a priority to understand how this type of liver fibrosis is similar to, and different from, pure hepatocellular injury driven liver fibrosis. Both types of liver fibrosis have the transformation of the hepatic stellate cell (HSC) into a myofibroblast as a key step. In metabolic syndrome, there is little evidence that metabolite changes such as high levels of glucose and free fatty acids are directly inducing HSC transdifferentiation, however, metabolite changes may lead to reductions in immunomodulatory and hepatoprotective molecules such as lipoxins, resolvins and Interleukin (IL)-22. Cells of the innate immune system are known to be important intermediaries between hepatocellular damage and HSC transdifferentiation, primarily by producing cytokines such as transforming growth factor-β (TGF-β) and platelet derived growth factor (PDGF). Resident and infiltrating macrophages are the dominant innate immune cells, but others (dendritic cells, neutrophils, natural killer T cells and mucosal-associated invariant T cells) also have important roles in inducing and resolving liver fibrosis. CD8+ and CD4+ T cells of the adaptive immune system have been identified to have greater profibrotic roles than previously realised by inducing hepatocyte death (auto-aggressive CD8+T) cells and cytokines producing (TH17 producing CD4+T) cells. Finally, the cellular networks present in NASH fibrosis are being identified and suggest that once fibrosis has developed cell-to-cell communication is dominated by myofibroblasts autocrine signalling followed by communication with cholangiocytes and endothelial cells, with myofibroblast-hepatocyte, and myofibroblast-macrophage signalling having minor roles. Such information is essential to the development of antifibrotic strategies for different stages of fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/egastro-2023-100015

Cites

149 of 149 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Hepatocyte-mediated activation of HSC, the innate and adaptive immune activation in the metabolic syndrome. Soluble mediators are in red. DAMPs, damage-associated molecular patterns; HSC, hepatic stellate cells; MAIT, mucosal-associated invariant T cells; NK, natural killer cells.
Figure 1 Hepatocyte-mediated activation of HSC, the innate and adaptive immune activation in the metabolic syndrome. Soluble mediators are in red. DAMPs, damage-associated molecular patterns; HSC, hepatic stellate cells; MAIT, mucosal-associated invariant T cells; NK, natural killer cells.CC BY-NC · PubMed Central
Figure 2 Effects of the innate and adaptive immune system on hepatocytes and HSC in the metabolic syndrome. HSC, hepatic stellate cell; IL, interleukin; MAIT, mucosal-associated invariant T; NK-T, natural killer T.
Figure 2 Effects of the innate and adaptive immune system on hepatocytes and HSC in the metabolic syndrome. HSC, hepatic stellate cell; IL, interleukin; MAIT, mucosal-associated invariant T; NK-T, natural killer T.CC BY-NC · PubMed Central
Figure 3 Single cell data from human NASH and mouse models reveals dominant autocrine signalling of hepatic stellate cells as well as paracrine signalling with cholangiocytes and endothelial cells.102 NASH, non-alcoholic steatohepatitis.
Figure 3 Single cell data from human NASH and mouse models reveals dominant autocrine signalling of hepatic stellate cells as well as paracrine signalling with cholangiocytes and endothelial cells.102 NASH, non-alcoholic steatohepatitis.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 149 references

Cited by

See all 28

Metadata

Authors
Mehal, W.
Affiliations
Yale University (US)
Corresponding author
Mehal, Wajahat
Venue
eGastroenterology
Publisher
BMJ
Published
2023-08
Volume
1
Issue
1
Pages
e100015
ISSN
  • 2766-0125 (ISSN-L)
  • 2976-7296
OpenAlex
W4386091184
Cited by
28
References
149
Citations by year
2026: 4 · 2025: 14 · 2024: 10
FWCI
4.69
Type
journal article
Language
en
Open access
Locations
  • eGastroenterology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
NIH (5U01AA026962-05)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Keywords
liver fibrosis, metabolic syndrome, nonalcoholic steatohepatitis, myofibroblasts, innate immunity, macrophages, dendritic cells, NKT cells, mucosal-associated invariant T cells, adaptive immunity, CD8+ T cells, Th17 cells, TGF-beta, platelet-derived growth factor, lipoxins, resolvins, IL-22, cholangiocytes, endothelial cells, autocrine signaling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms of liver fibrosis in metabolic syndrome. https://app.cochat.ai/papers/10.1136/egastro-2023-100015
The paper
Mehal, W. (2023). Mechanisms of liver fibrosis in metabolic syndrome. eGastroenterology. https://doi.org/10.1136/egastro-2023-100015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.